| Filed On | Filing |
|---|---|
| 15 Oct 2025 |
8-K/A: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +4 more
On October 10, 2025, ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain accredited investors (the “Purchasers”) pursuant to wh... |
| 13 Dec 2019 | 8-K/A: Entry into a Material Definitive Agreement |
| 13 Apr 2018 | 8-K/A: Shareholder Director Nominations |
Loading...